Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial

Autor: Felice Gragnano, Marcel Zwahlen, Pascal Vranckx, Dik Heg, Kurt Schmidlin, Christian Hamm, Philippe Gabriel Steg, Giuseppe Gargiulo, Eugene P. McFadden, Yoshinobu Onuma, Ply Chichareon, Edouard Benit, Helge Möllmann, Luc Janssens, Sergio Leonardi, Aleksander Zurakowski, Alessio Arrivi, Robert Jan Van Geuns, Kurt Huber, Ton Slagboom, Paolo Calabrò, Patrick W. Serruys, Peter Jüni, Marco Valgimigli, Stephan Windecker, Mohamed Abdellaoui, David Adlam, Ibrahim Akin, Agustin Albarran Gonzalez‐Trevilla, Manuel Almeida, Pedro Alves Lemos Neto, Adel Aminian, Richard Anderson, Rick Andreae, Michael Angioi, Taku Asano, Emanuele Barbato, Peter Barlis, Pascal Barraud, Olivier Bertrand, Farzin Beygui, Leonardo Bolognese, Roberto Botelho, Coby Bouwman, Marco Bressers, Philippe Brunel, Pawel Buszman, Ian Buysschaert, Pedro Canas da Silva, Didier Carrie, Angel Cequier, Chun Chin Chang, Saqib Chowdhary, Carlos Collet, Antonio Colombo, James Cotton, Rui Cruz Ferreira, Salvatore Curello, Nick Curzen, Judith de Bot, Tone de Vreede, Georg Delle Karth, Lynn Dijksma, Marcello Dominici, István Édes, Eric Eeckhout, Ingo Eitel, József Faluközy, Farzin Fath‐Ordoubadi, Maurizio Ferrario, Geza Fontos, Jose Francisco Diaz, Edgard Freitas Quintella, Bernhard Frey, Guy Friedrich, Gavin Galasko, Grzegorz Galuszka, Vasco Gama Ribeiro, Scot Garg, Tobias Geisler, Valeri Gelev, Art Ghandilyan, Javier Goicolea, Tommaso Gori, Ana Guimarães, Michael Haude, Pieter Heijke, Rosa Ana Hernández Antolin, David Hildick‐Smith, Dorien Hillen, Ina Hoekman, Sjoerd Hofma, Lene Holmvang, Stephen Hoole, Iván Horváth, Annemarie Hugense, Karim Ibrahim, Andres Iñiguez, Karl Isaaz, Zoltán Jambrik, Pawel Jasionowicz, Judith Jonk, Werner Jung, Yuki Katagiri, Norihiro Kogame, Tian Hai Koh, René Koning, Mariana Konteva, Zsolt Kőszegi, Florian Krackhardt, Yvonne Kreuger, Neville Kukreja, Boudijn Ladan, Pierre Lantelme, Sergio Leandro, Gregor Leibundgut, Christoph Liebetrau, Wietze Lindeboom, Carlos Macaya Miguel, François Mach, Michael Magro, Luc Maillard, Negar Manavifar, Laura Mauri, Eugene McFadden, Bela Merkely, Yosuke Miyazaki, Adam Młodziankowski, Tiziano Moccetti, Rodrigo Modolo, Helge Möllman, Jean‐François Morelle, Aris Moschovitis, Michael Munndt Ottesen, Martin Muurling, Christoph Kurt Naber, Franz‐Josef Neumann, Keith Oldroyd, Paul Ong, Sanne Palsrok, Ivo Petrov, Sylvain Plante, Janusz Prokopczuk, Tessa Rademaker‐Havinga, Christopher Raffel, Benno Rensing, Marco Roffi, Kees‐Jan Royaards, Manel Sabate, Volker Schächinger, Tim Seidler, Antonio Serra Peñaranda, Patrick Serruys, Lali Sikarulidze, Osama I Soliman, Amanda Sousa, Ernest Spitzer, Rod Stables, Gabriel Steg, Clemens Steinwender, Eduardas Subkovas, Harry Suryapranata, Kuniaki Takahashi, Suneel Talwar, Emmanuel Teiger, Addy Ter Weele, Eva Teurlings, Attila Thury, Jan Tijssen, Gincho Tonev, Diana Trendafilova‐Lazarova, Carlo Tumscitz, Victor Umans, Imre Ungi, Veselin Valkov, Pim van der Harst, Robert Jan van Geuns, Cokky van Meijeren, Dobrin Vassilev, Vasil Velchev, Esther Velthuizen, Freek Verheugt, Natalia Vlcek, Jürgen Vom Dahl, Mathias Vrolix, Simon Walsh, Nikos Werner, Maarten Witsenburg, Azfar Zaman, Krzysztof Żmudka, Bernhard Zrenner, Robert Zweiker

Publikováno v: Gragnano, Felice; Zwahlen, Marcel; Vranckx, Pascal; Heg, Dik; Schmidlin, Kurt; Hamm, Christian; Steg, Philippe Gabriel; Gargiulo, Giuseppe; McFadden, Eugene P; Onuma, Yoshinobu; Chichareon, Ply; Benit, Edouard; Möllmann, Helge; Janssens, Luc; Leonardi, Sergio; Zurakowski, Aleksander; Arrivi, Alessio; Van Geuns, Robert Jan; Huber, Kurt; Slagboom, Ton; ... (2022). Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial. Journal of the American Heart Association, 11(10), e024291. American Heart Association 10.1161/JAHA.121.024291
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 11
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 11, 10

Background In the GLOBAL LEADERS trial, ticagrelor monotherapy beyond 1 month compared with standard antiplatelet regimens after coronary stent implantation did not improve outcomes at intention‐to‐treat analysis. Considerable differences in trea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea2e4d3da911a7a0812873aa1379421f
https://doi.org/10.1161/jaha.121.024291

Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial

Autor: Robbert de Winter de Winter, Azfar Zaman, Hironori Hara, Chao Gao, Masafumi Ono, Scot Garg, Pieter Smits Smits, Pim Tonino Tonino, Sjoerd Hofma Hofma, Raul Moreno, Anirban Choudhury, Ivo Petrov, Angel Cequier, Antonio Colombo, Upendra Kaul, Yoshinobu Onuma, Patrick Serruys Serruys

Publikováno v: Eurointervention, 18, 6, pp. 492-502
EuroIntervention, 18(6), 492-502. EuroPCR
Eurointervention, 18, 492-502

Background: In the TALENT study, the sirolimus-eluting ultrathin strut Supraflex stent was non-inferior to the XIENCE stent for a device-oriented composite endpoint (DoCE: defined as cardiac death, target vessel myocardial infarction [TV-MI], or clin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d7f32f53a1d6eca047ae9cb9627b738
https://repository.ubn.ru.nl/handle/2066/284417

[Proton pump inhibitors when using clopidogrel: balance between necessity and disadvantages]

Autor: Kim, van der Elst, Berdien, Oortgiesen, Willemien, Kruik-Kollöffel, Mels, Hoogendoorn, Sjoerd, Hofma, Eric, van Roon

Publikováno v: Nederlands tijdschrift voor geneeskunde. 163

Rationale When patients are using carbasalate calcium or acetylsalicylic acid (ASA), it is recommended to prescribe a proton pump inhibitor (PPI) in order to prevent gastrointestinal (GI) bleeding. Should this recommendation also be followed for pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::da96128ed717c894b7ec42ab3f45072c
https://pubmed.ncbi.nlm.nih.gov/31166094

Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease

Autor: Angela, Hoye, Pedro A, Lemos, Chourmouzios A, Arampatzis, Francesco, Saia, Kengo, Tanabe, Muzaffer, Degertekin, Sjoerd, Hofma, Eugene, McFadden, Georgios, Sianos, Pieter C, Smits, Willem J, van der Giessen, Pim, de Feyter, Ron T, van Domburg, Patrick W, Serruys

Publikováno v: The Journal of invasive cardiology. 16(5)

The use of bare stents for the percutaneous intervention of saphenous vein bypass grafts (SVGs) is associated with a high subsequent rate of restenosis. To assess the impact of the sirolimus-eluting stent (SES), we studied 19 consecutive patients who

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::929bf4a2ded22db3210cc82ef2279a12
https://pubmed.ncbi.nlm.nih.gov/15152124

Stent fracture and restenosis in the drug-eluting stent era.

Autor: Georgios Sianos, Sjoerd Hofma, Jurgen M.R. Ligthart, Francesco Saia, Angela Hoye, Pedro A. Lemos, Patrick W. Serruys

Publikováno v: Catheterization & Cardiovascular Interventions; Jan2004, Vol. 61 Issue 1, p111-116, 6p